Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3286)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 14, 2025 (publication date) through Feb 13, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Ren S, Song LN, Zhao R, Tian Y, Wang ZQ. Serum exosomal hsa-let-7f-5p: A potential diagnostic biomarker for metastatic pancreatic cancer detection. World J Gastroenterol 2025; 31(26): 109500 [PMID: 40678708 DOI: 10.3748/wjg.v31.i26.109500] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Ren S, Song LN, Zhao R, Tian Y, Wang ZQ. Serum exosomal hsa-let-7f-5p: A potential diagnostic biomarker for metastatic pancreatic cancer detection. World J Gastroenterol 2025; 31(26): 109500 [PMID: 40678708 DOI: 10.3748/wjg.v31.i26.109500] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v31/i26/109500.htm |
| Number | Citing Articles |
| 1 |
Bingqian Lin, Duanyu Lin, Xiaodan Ou, Jinwen Wang, Shun Yu, Gan Chen, Junping Wen. Brown adipose tissue activation and cardiovascular risk following PD-1 antibody therapy in cancer patients: a retrospective cohort study. European Journal of Medical Research 2025; 30(1) doi: 10.1186/s40001-025-03463-w
|
| 2 |
Fong-Yu Cheng, Boguslaw Tomanek, Barbara Blasiak. Current Developments of Iron Oxide Nanomaterials as MRI Theranostic Agents for Pancreatic Cancer. Journal of Nanotheranostics 2025; 6(3): 22 doi: 10.3390/jnt6030022
|
| 3 |
Yeo Gyeong Ko, See Young Lee, Won Kyu Lee, Ji Hoon Park, Sang Hoon Lee, Kyung In Shin, Jiyoung Keum, Jee Hoon Kim, Jung Hyun Jo, Sung Ill Jang, Jae Hee Cho, Galam Leem, Moon Jae Chung, Jeong Youp Park, Seungmin Bang, Seung Woo Park, Seung Up Kim, Hee Seung Lee. Early prediction of liver metastasis in pancreatic cancer using routine clinical data: an externally validated machine learning model. BMC Cancer 2025; 26(1) doi: 10.1186/s12885-025-15285-4
|
| 4 |
Roshni Bibi, Arunika Koley, Koustav Sarkar. Therapeutic potential of exosomes in malignancies: From drug delivery to clinical application. Pathology - Research and Practice 2026; 279: 156381 doi: 10.1016/j.prp.2026.156381
|
| 5 |
Patricio M. Polanco, Tamas Gonda, Erkut Borazanci, Evan S. Glazer, Jose G. Trevino, George DeMuth, Lisa Ford, Thomas King, Norma A. Palma, Randall E. Brand. Confirmatory Clinical Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma. Current Oncology 2025; 32(11): 638 doi: 10.3390/curroncol32110638
|
| 6 |
Daria Kwaśniewska, Marta Fudalej, Anna Maria Badowska-Kozakiewicz, Aleksandra Czerw, Andrzej Deptała. Neoadjuvant Therapy or Upfront Surgery for Pancreatic Cancer—To Whom, When, and How?. Cancers 2025; 17(15): 2584 doi: 10.3390/cancers17152584
|
| 7 |
Sounetra Choudhury, Akash Bararia, Arunima Maiti, Sayan Saha, Sumit Mukherjee, Shuchismita Chakraborty, Arnab Pal, Shibajyoti Ghosh, Bitan K. Chattopadhay, Sudeep Banerjee, Supriyo Ghatak, Debabrata Ghosh Dastidar, Nilabja Sikdar. Identification of a chromatin-modifying gene-histone lysine N-methyl transferase (KMT2C/MLL3) as a potential immunomodulator oncogene in Indian pancreatic cancer patients. European Journal of Medical Research 2025; 31(1) doi: 10.1186/s40001-025-03661-6
|
| 8 |
Dailei Qin, Kewei Huang, Zehui Yao, Lingmin Jiang, Qi Zhu, Jianzhong Cao, Shengping Li. Development of a nomogram integrating immune checkpoints, fibrosis indicators, and clinicopathological characteristics to predict overall survival in pancreatic cancer: a retrospective analysis. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1688440
|
| 9 |
Yijiao Ning, Junhao Mu, Zhao Zhang, Yuezhou Zhang, Changlin Tang. Pancreatic cancer in China: the analysis of cancer mortality and burden in China, 2008–2021. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-15223-4
|
| 10 |
Luigi Brancato, Damar Osok, Laurent Van den Bossche, Eric Van Cutsem, Susan Bates, Johan Van den Bossche, Johannes Bogers. CA19-9 as a Dynamic Biomarker for Continuous Monitoring of Therapeutic Efficacy in Pancreatic Adenocarcinoma. Cancers 2025; 17(24): 3902 doi: 10.3390/cancers17243902
|
| 11 |
Miana Gabriela Pop, Cristina Pojoga, Ioana Bartoș, Florina Gabor-Harosa, Sandu Brînzilă, Caius Mihai Breazu, Adrian Bartoș. Intraoperative Elastography in Pancreatic Cancer—Clinical Applications and Systematic Review of the Literature. Cancers 2026; 18(3): 473 doi: 10.3390/cancers18030473
|
| 12 |
Mengyuan Lu, Donglin Jiang, Jiaxin Zhang, Ling Liu, Yajing Shen, Tiandong Li, Peng Wang, Jianxiang Shi, Keyan Wang, Hua Ye. Diagnostic valuation of MMP family members as biomarkers for pancreatic cancer: a systematic review and meta-analysis. Biomarkers in Medicine 2025; 19(18): 909 doi: 10.1080/17520363.2025.2571394
|
| 13 |
Zinan Zhang, Yanbin Wei, Jiafei Peng, Yan Zhao, Xin Yao, Ye Zong. Does adjunctive endoscopic biliary drainage improve outcomes beyond glucocorticoids alone in IgG4-related pancreatobiliary disease?. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-04356-2
|
| 14 |
Chengzhou Pa, Shijun Shen, Shuxian Song, Kuan Li, Gang Chen. Comparative trends in pancreatic cancer burden and risk factors in the USA and China (1990–2021): insights from GBD analysis. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-04470-1
|
| 15 |
Yu Kato, Naoki Yamamoto, Yuichiro Uchida, Noriko Hiramatsu, Takato Ozeki, Yukari Minobe, Yukika Hasegawa, Sho Kawabe, Hikaru Yabuuchi, Seiji Yamada, Yuko Hata, Eiji Sugihara, Tetsuya Takimoto, Kuniaki Saito, Takeshi Takahara, Koichi Suda, Osamu Nagano, Hideyuki Saya. Rapid Drug Sensitivity Profiling via a Novel High-Success-Rate Culture Method for Patient-Derived Pancreatic Cancer: An Exploratory Preclinical Platform for Advancing Clinical Applications and Drug Development. Cells 2026; 15(4): 313 doi: 10.3390/cells15040313
|
| 16 |
Weiliang Jiang, Zhiyuan Cheng, Rong Mu, Haoran Sun, Zihao Guo, Guo Yu, Dongyan Wang, Lijuan Yang. Machine learning-optimized metabolic biomarker panel for precision screening of early-stage pancreatic cancer in new-onset diabetes. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1684608
|
| 17 |
Zhenhao Huang, Jixing Wang, Baoyong Zhou, Rui Liao, Jie Xu, Peng Guo, Zhipeng Liu, Nan You, Rui Tao, Qihui Hu. Preoperative serum prealbumin as a prognostic marker for survival after gallbladder cancer resection: a multicenter study. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-04472-z
|
| 18 |
Xianhong Yang, Zhenji Xu, Yangyingqiu Liu, Tao Feng. Aggressive atypical cystic fibromatosis of the pancreas: a case report and literature review. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1596535
|
| 19 |
Zhongjun Jiang, Lanlan Wang, Zhongrun He, Lian Guo, Wen Luo, Ying Fu, Qiyu Xiao, Guanglan Chen, Yinzi Liu. Mitophagy-related gene TRIP13 predicts prognosis and immune response and promotes proliferation and migration in vitro and in vivo of clear cell renal cell carcinoma. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1736086
|
| 20 |
Jan-Paul Gundlach, Thorben Fedders, Steffen Markus Heckl, Thomas Becker, Julius Pochhammer. Impact of Becoming a Certified Oncologic Center of Pancreatic Surgery: Evaluation of Single-Center Perioperative Results and Quality of Life Before and After Implementation of a Certified Center. Diseases 2025; 13(11): 353 doi: 10.3390/diseases13110353
|
| 21 |
Jia Peng, Shiyao Xie, Xinnan Liao, Mengnan Tai, Zixuan Nie, Yaoqi Wang, Zhiyuan Chen, Zheng Wang, Ya Peng. Multi-structure CT radiomics-based consensus model for the diagnosis of pancreatic ductal adenocarcinoma and vascular involvement. Computers in Biology and Medicine 2026; 204: 111542 doi: 10.1016/j.compbiomed.2026.111542
|
| 22 |
Zhicheng Yi, Fanhua Zhou, Xinkai Zhao. The relationship between serum CA50, CA242, and SAA levels and clinical pathological characteristics and prognosis in patients with pancreatic cancer. Open Medicine 2025; 20(1) doi: 10.1515/med-2025-1304
|
| 23 |
Ewa Grudzińska, Paweł Szmigiel, Karolina Majewska, Sławomir Mrowiec, Zenon P. Czuba. Pancreatic Cancer and Benign Pancreatic Cystic Lesions: Differences in Cytokines, Growth Factors, and Immunological Markers Concentrations in Serum and Cystic Fluid. Cancers 2025; 17(17): 2783 doi: 10.3390/cancers17172783
|
| 24 |
Shu-Jun Gu, Liu Xu, Hong-Kun Zhou, Jie Yang. Metabolomics to Reveal Diagnostic Biomarkers in CA19-9 Negative Pancreatic Ductal Adenocarcinoma: A Cross-Sectional Study. Journal of Proteome Research 2026; 25(1): 307 doi: 10.1021/acs.jproteome.5c00615
|
| 25 |
Xianfeng Hui, Xiaowei Tian, Shihuan Ding, Aiping Sun, Tiesuo Zhao, Hui Wang. Reprogramming the tumor microenvironment to overcome immunotherapy resistance in pancreatic cancer. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1717062
|
| 26 |
Baoxuan Wang, Yan Wang, Dong Zhao, Houjun Zhang, Qi Liu, Guanying Yu, Jie Jiao. Case Report: Biweekly TAS-102 and bevacizumab as maintenance therapy for recurrent and metastatic pseudomyxoma peritonei following palliative cytoreduction. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1631286
|